[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100515670":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":101,"collaborators":105,"id":109,"slug":110,"hasResults":111,"nctId":112,"briefTitle":113,"officialTitle":114,"acronym":115,"eligibilityCriteria":116,"healthyVolunteers":111,"sex":117,"minAge":118,"maxAge":119,"enrollmentInfo":120,"targetDuration":25,"studyType":123,"phases":124,"briefSummary":126,"conditions":127,"keywords":129,"overallStatus":58,"whyStopped":25,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":142},{"fullName":5,"class":6},"McGill University Health Centre\u002FResearch Institute of the McGill University Health Centre","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ERCP alone","ACTIVE_COMPARATOR","ERCP procedure alone and management of MGOO will be on a wait-and-see approach, using endoscopic interventions performed only if obstruction is clinically diagnosed",[13],"Procedure: ERCP alone",{"label":15,"type":16,"description":17,"interventionNames":18},"ERCP + ProEUS-GE","EXPERIMENTAL","ERCP with prophylactic eus-guided gastroenterostomy",[19],"Procedure: ERCP +ProEUS-GE",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","ERCP with biliary stenting will be performed alone. ERCP is part of standard of care for biliary drainage. An endoscope is advanced to the small intestines and a metal stent is inserted through the tumor instead of bypassing the tumor to effectively drain the biliary system under x-ray guidance.\n\nManagement of MGOO will be on a wait-and-see approach, using endoscopic interventions performed only if obstruction is clinically diagnosed",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"ERCP +ProEUS-GE","ERCP is performed as described above. following the ERCP, the scoped is switched for an echoendoscope which is advanced to the stomach. A stent is then placed between the stomach and the small intestines, creating a connection (ProEUS-GE).",[15],[31,37],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"Yen-I Chen, MD","CONTACT","(514) 934-1934","65651","yen-i.chen@mgcill.com",{"name":38,"role":33,"phone":25,"phoneExt":25,"email":39},"Myriam Martel, MSc","myriam.martel@muhc.mcgill.ca",[41,56,64,75,88],{"facility":42,"status":43,"city":44,"state":25,"zip":25,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Jewish General Hospital","NOT_YET_RECRUITING","Montreal","Canada","CA",{"type":48,"coordinates":49},"Point",[50,51],-73.58781,45.50884,{"lat":51,"lon":50},[54],{"name":55,"role":33,"phone":25,"phoneExt":25,"email":25},"Corey Miller, MD",{"facility":57,"status":58,"city":44,"state":25,"zip":25,"country":45,"countryCode":46,"cosmosGeoPoint":59,"geoPoint":61,"contacts":62},"McGill University Health Center","RECRUITING",{"type":48,"coordinates":60},[50,51],{"lat":51,"lon":50},[63],{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":43,"city":66,"state":25,"zip":25,"country":45,"countryCode":46,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"St-Michael's Hospital (SMH)","Toronto",{"type":48,"coordinates":68},[69,70],-79.39864,43.70643,{"lat":70,"lon":69},[73],{"name":74,"role":33,"phone":25,"phoneExt":25,"email":25},"Natalia C. Calo, MD",{"facility":76,"status":43,"city":77,"state":25,"zip":25,"country":78,"countryCode":79,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Hôpital Privé des Peupliers","Paris","France","FR",{"type":48,"coordinates":81},[82,83],2.3488,48.85341,{"lat":83,"lon":82},[86],{"name":87,"role":33,"phone":25,"phoneExt":25,"email":25},"Gianfranco Donatelli, MD",{"facility":89,"status":43,"city":90,"state":25,"zip":25,"country":91,"countryCode":92,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Asian Institute of Gastroenterology","Hyderabad","India","IN",{"type":48,"coordinates":94},[95,96],78.45636,17.38405,{"lat":96,"lon":95},[99],{"name":100,"role":33,"phone":25,"phoneExt":25,"email":25},"Sundeep Lakhtakia, MD",{"type":102,"investigatorFullName":103,"investigatorTitle":104,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Yen-I Chen","assistant professor of medicine",[106,107],{"name":42,"class":6},{"name":108,"class":6},"Unity Health Toronto","100515670","prophylactic-eus-guided-gastroenterostomy-in-advanced-periampullary-cancers-100515670",false,"NCT05994521","Prophylactic EUS-guided Gastroenterostomy in Advanced Periampullary Cancers","Prophylactic EUS-guided Gastroenterostomy in Advanced Periampullary Cancers: a Multicenter Randomized Controlled Trial","INTERCEPT","Inclusion Criteria (all of the following):\n\n1. Radiological diagnosis of a periampullary cancer that is precluded from upfront surgical resection of curative intent due to advanced tumor stage. These include locally advanced or metastatic cancers of the pancreatic head, distal bile duct, duodenum, or ampulla. cancers.\n2. Elevated liver function tests requiring ERCP without evidence of MGOO of significant gastroparesis (see exclusion criterion #3 and #4)\n3. ECOG 0 or 1\n4. ASA\\\u003C4\n5. Provision of informed consent\n\nExclusion Criteria (any of the following):\n\n1. Patient with clinical and radiological evidence of malignant gastric outlet obstruction defined as Gastric Outlet Obstruction Scoring System (GOOSS) of \\\u003C 3 with radiological and\u002For endoscopic evidence of a mechanical obstruction from a gastric or duodenal stricture. GOOSS is a validated tool for assessing MGOO and is scored based on the diet tolerated by the patient: 0 for no oral intake, 1 for liquids only, 2 for soft diet, and 3 for low residue or full diet.\n2. Gastroparesis with a Gastroparesis Cardinal Symptom Index (GCSI) of \\>2. Gastroparesis is defined as having symptoms of MGOO without radiological and\u002For endoscopic evidence of mechanical obstruction.\n3. Uncorrectable coagulopathy and\u002For thrombocytopenia\n4. Age \\\u003C 18 or ≥ 85\n5. Evidence of peritoneal carcinomatosisAscites\n6. Liver metastasis \\> 30% of the liver volume\n7. Portal hypertension with gastroesophageal varices and\u002For ascites\n8. Surgically altered upper gastrointestinal anatomy","ALL","18 Years","85 Years",{"count":121,"type":122},110,"ESTIMATED","INTERVENTIONAL",[125],"NA","The goal of this randomized controlled trial is to investigate the effectiveness and safety of Prophylactic EUS-gastroenterostomy (ProEUS-GE) as a preventative approach for malignant gastric outlet obstruction (MGOO) in men and women aged 18 years or older diagnosed with periampullary cancer.\n\nThe main question this study aims to answer is can ProEUS-GE effectively prevent the occurrence of MGOO in patients with periampullary cancer?\n\nPatients will be randomly assigned to one of two groups: Group 1 (ERCP alone) or Group 2 (ERCP + ProEUS-GE). The study will compare the outcomes between these groups to determine the effectiveness of ProEUS-GE in preventing MGOO.\n\nResearchers will compare Group 1 (ERCP alone) with Group 2 (ERCP + ProEUS-GE) to see if the addition of ProEUS-GE leads to a reduced occurrence of MGOO in patients with periampullary cancer.\n\nThe primary endpoint is the rate of malignant gastric outlet obstruction.",[128],"Cancer Gi",[130,131,132],"periampullary cancer","ERCP","EUS-Guided gastroeterostomy","2024-09-27",{"date":135,"type":136},"2024-10-01","ACTUAL",{"date":138,"type":136},"2024-04-09",{"date":140,"type":122},"2027-08",{"name":5,"class":6},5]